Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

792 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)

NCT00239421

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Med. Uni.-Klinik Graz Graz, Austria
  • Boehringer Ingelheim Investigational Site Vienna, Austria
  • Klinikum Kreuzschwestern Wels Wels, Austria
  • Sint-Vincentius Ziekenhuis Antwerp, Belgium
View all 56 locations
View Trial Details
Completed

SPIRIVA in Ususal Care

NCT00274079

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Foresterhill Healthcentre Aberdeen, United Kingdom
  • Boehringer Ingelheim Investigational Site Airdrie, United Kingdom
  • Boehringer Ingelheim Investigational Site Atherstone, United Kingdom
  • Boehringer Ingelheim Investigational Site Barry, United Kingdom
View all 44 locations
View Trial Details
Completed

Efficacy of Tiotropium in Patients of African Descent With Chronic Obstructive Pulmonary Disease

NCT00106821

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Cooper Green Hospital Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • David Geffen School of Medicine Los Angeles, California, United States
View all 19 locations
View Trial Details
Completed

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00274547

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Carl T. Hayden VA Medical Center Phoenix, Arizona, United States
  • Southern Arizona VA Health Care System Tuscon, Arizona, United States
  • VA Long Beach Healthcare System Long Beach, California, United States
View all 26 locations
View Trial Details
Completed

Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

NCT00239460

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Attn: William C. Bailey, M.D. Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Olive View UCLA Medical Center Sylmar, California, United States
  • Rocky Mountain Center for Clinical Research Wheat Ridge, Colorado, United States
View Trial Details
Completed

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

NCT00274053

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Aix-les-Bains, France
  • Hôpital Privé Antony Antony, France
  • Boehringer Ingelheim Investigational Site Bordeaux, France
  • Boehringer Ingelheim Investigational Site Cambo-les-Bains, France
View all 27 locations
View Trial Details
Completed

Tiotropium (Spiriva) Rehabilitation Study

NCT00274521

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • Attention: John E. Hodgkin, M.D. Deer Park, California, United States
  • Boehringer Ingelheim Investigational Site Long Beach, California, United States
View all 19 locations
View Trial Details
Completed

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

NCT00239408

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Hospital Garcia de Orta Almada, Portugal
  • Hospital Fernando Fonseca Amadora, Portugal
  • Hospital Santo Espírito de Angra do Heroismo Angra Do Heroismo - Açores, Portugal
  • Hospital Infante D. Pedro Aveiro, Portugal
View all 33 locations
View Trial Details
Completed

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

NCT00240435

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
  • Boehringer Ingelheim Investigational Site Downey, California, United States
  • University of California - Los Angeles Los Angeles, California, United States
  • Boehringer Ingelheim Investigational Site Palo Alto, California, United States
View all 25 locations
View Trial Details

Related conditions